Less treatment with biologics, 5-aminosalisylic acids, and immunomodulators is associated with higher frailty risk among older adults with IBD. Older adults with inflammatory bowel disease (IBD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback